Effect of palonosetron and dexamethasone administration on the prevention of gastrointestinal symptoms in hepatic arterial chemoembolization with epirubicin.

Sakamoto, Tatsuhiko; Saito, Yoshitaka; Kobayashi, Masaki; Yamada, Takehiro; Takekuma, Yoh; Nakai, Masato; Ogawa, Koji; Iseki, Ken; Sugawara, Mitsuru

Sakamoto, Tatsuhiko; Saito, Yoshitaka; Kobayashi, Masaki; Yamada, Takehiro; Takekuma, Yoh; Nakai, Masato; Ogawa, Koji; Iseki, Ken; Sugawara, Mitsuru.

Afiliação

Sakamoto T; Department of Pharmacy, Hokkaido University Hospital, Kita 14-jo, Nishi 5-chome, Kita-ku, Sapporo, 060-8648, Japan.
Saito Y; Department of Pharmacy, Hokkaido University Hospital, Kita 14-jo, Nishi 5-chome, Kita-ku, Sapporo, 060-8648, Japan.
Kobayashi M; Laboratory of Clinical Pharmaceutics & Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12-jo, Nishi 6-chome, Kita-ku, Sapporo, 060-0812, Japan.
Yamada T; Department of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, 15-4-1, Maeda 7-jo, Teine-ku, Sapporo, 006-8585, Japan.
Takekuma Y; Department of Pharmacy, Hokkaido University Hospital, Kita 14-jo, Nishi 5-chome, Kita-ku, Sapporo, 060-8648, Japan.
Nakai M; Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12-jo, Nishi 6-chome, Kita-ku, Sapporo, 060-0812, Japan.
Ogawa K; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, Kita 15-jo, Nishi 7-chome, Kita-ku, Sapporo, 060-8638, Japan.
Iseki K; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, Kita 15-jo, Nishi 7-chome, Kita-ku, Sapporo, 060-8638, Japan.
Sugawara M; Laboratory of Clinical Pharmaceutics & Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12-jo, Nishi 6-chome, Kita-ku, Sapporo, 060-0812, Japan.

Support Care Cancer ; 28(7): 3251-3257, 2020 Jul.

Article em En | MEDLINE | ID: mdl-31732854

Assuntos

Antieméticos/uso terapêutico; Carcinoma Hepatocelular/terapia; Quimioembolização Terapêutica/efeitos adversos; Quimioembolização Terapêutica/métodos; Dexametasona/uso terapêutico; Epirubicina/administração & dosagem; Gastroenteropatias/prevenção & controle; Neoplasias Hepáticas/terapia; Palonossetrom/uso terapêutico; Dor Abdominal/etiologia; Dor Abdominal/prevenção & controle; Adulto; Idoso; Antibióticos Antineoplásicos/administração & dosagem; Antibióticos Antineoplásicos/efeitos adversos; Feminino; Gastroenteropatias/etiologia; Humanos; Masculino; Pessoa de Meia-Idade; Náusea/etiologia; Náusea/prevenção & controle; Estudos Retrospectivos; Vômito/etiologia; Vômito/prevenção & controle

Palavras-chave

5-HT3 antagonist; Dexamethasone; Epirubicin; Nausea; Postembolization syndromes; Transcatheter arterial chemoembolization (TACE)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dexametasona / Epirubicina / Quimioembolização Terapêutica / Carcinoma Hepatocelular / Palonossetrom / Gastroenteropatias / Neoplasias Hepáticas / Antieméticos Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google